Annual CFF
Summary
- Current Value
- As of today, DVAX annual cash from financing is -$102.02M, down -7460.53% on
- Historical Performance
- DVAX annual cash from financing is down -282.90% over the past 3 years, and down -166.09% over the past 5 years
- All-Time High Comparison
- DVAX annual cash from financing is currently -154.31% below its historical high of $187.84M set on
- 3-Year Low Comparison
- DVAX annual cash from financing is at its 3-year low
- Sector Comparison
- DVAX annual cash from financing is higher than 9.67% of companies in Healthcare sector
Cash From Financing Chart
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual Cash From Financing | -$102.02M | -7460.5% | -282.9% | -166.1% | -562.5% | |
| Quarterly Cash From Financing | -$61.00K | -102.5% | -100.8% | -104.3% | -102.9% | |
| TTM Cash From Financing | -$202.74M | -10000.0% | -693.0% | -285.3% | -416.9% | |
| Price | $15.41 | +22.1% | +50.0% | +208.8% | -52.9% | |
| Annual Cash From Operations | $66.51M | -33.9% | -80.2% | +154.8% | +298.2% | |
| Annual Cash From Investing | -$18.04M | +88.3% | -226.8% | +57.8% | -190.7% | |
| Annual Dividends Paid | $0.00 | 0.0% | 0.0% | 0.0% | 0.0% | |
| Annual Total Debt | $254.42M | -1.0% | -1.1% | +15.9% | +100.0% | |
| Shares Outstanding | 117.43M | -6.4% | -8.0% | +6.6% | – |
Cash From Financing Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $19.53M | N/A | -622.5% |
| 5Y | $109.50M | N/A | -193.2% |
| All | $187.84M | -154.3% |
Cash From Financing Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | -$102.02M | at low | |
| 5Y | -$102.02M | at low | |
| All | -$102.02M | at low |
Cash From Financing History
FAQ
What is the current annual cash from financing of DVAX?
As of today, DVAX annual cash from financing is -$102.02M
What is 1-year change in DVAX annual cash from financing?
DVAX annual cash from financing is down -7460.53% year-over-year
What is 3-year change in DVAX annual cash from financing?
DVAX annual cash from financing is down -282.90% over the past 3 years
How far is DVAX annual cash from financing from its all-time high?
DVAX annual cash from financing is currently -154.31% below its historical high of $187.84M set on December 31, 2017
How does DVAX annual cash from financing rank versus sector peers?
DVAX annual cash from financing is higher than 9.67% of companies in Healthcare sector
When is DVAX next annual earnings release?
The next annual earnings release for DVAX is on
Quarterly CFF
Summary
- Current Value
- As of today, DVAX quarterly cash from financing is -$61.00K, up +99.92% on
- Historical Performance
- DVAX quarterly cash from financing is down -102.46% year-over-year, and down -100.76% over the past 3 years
- All-Time High Comparison
- DVAX quarterly cash from financing is currently -100.04% below its historical high of $153.01M set on
- 3-Year Low Comparison
- DVAX quarterly cash from financing is +99.94% above its 3-year low of -$98.88M reached on
- Sector Comparison
- DVAX quarterly cash from financing is higher than 31.28% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly Cash From Financing | -$61.00K | +99.9% | -102.5% | -100.8% | -104.3% | |
| Annual Cash From Financing | -$102.02M | – | -7460.5% | -282.9% | -166.1% | |
| TTM Cash From Financing | -$202.74M | -1.3% | -10000.0% | -693.0% | -285.3% | |
| Price | $15.41 | +48.9% | +22.1% | +50.0% | +208.8% | |
| Quarterly Cash From Operations | $33.83M | +44.4% | +73.8% | -45.0% | +221.6% | |
| Quarterly Cash From Investing | $27.32M | -71.2% | +276.7% | +123.0% | +1430.2% | |
| Quarterly Dividends Paid | $0.00 | 0.0% | 0.0% | 0.0% | 0.0% | |
| Quarterly Total Debt | $289.22M | -0.1% | +13.6% | +12.2% | +32.4% | |
| Shares Outstanding | 117.43M | – | -6.4% | -8.0% | +6.6% |
Quarterly Cash From Financing Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$61.00K | at high | |
| 3Y | $2.99M | -102.0% | |
| 5Y | $32.30M | -100.2% | |
| All | $153.01M | -100.0% |
Quarterly Cash From Financing Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$98.88M | N/A | +99.9% |
| 3Y | -$98.88M | +99.9% | |
| 5Y | -$98.88M | +99.9% | |
| All | -$98.88M | +99.9% |
Quarterly Cash From Financing History
FAQ
What is the current quarterly cash from financing of DVAX?
As of today, DVAX quarterly cash from financing is -$61.00K
What is DVAX quarterly cash from financing most recent change?
DVAX quarterly cash from financing was up +99.92% on September 30, 2025
What is 1-year change in DVAX quarterly cash from financing?
DVAX quarterly cash from financing is down -102.46% year-over-year
How far is DVAX quarterly cash from financing from its all-time high?
DVAX quarterly cash from financing is currently -100.04% below its historical high of $153.01M set on September 30, 2015
How does DVAX quarterly cash from financing rank versus sector peers?
DVAX quarterly cash from financing is higher than 31.28% of companies in Healthcare sector
When is DVAX next earnings release?
The next earnings release for DVAX is on
TTM CFF
Summary
- Current Value
- As of today, DVAX TTM cash from financing is -$202.74M, down -1.27% on
- Historical Performance
- DVAX TTM cash from financing is down -14741.58% year-over-year, and down -693.00% over the past 3 years
- All-Time High Comparison
- DVAX TTM cash from financing is currently -178.80% below its historical high of $257.28M set on
- 3-Year Low Comparison
- DVAX TTM cash from financing is at its 3-year low
- Sector Comparison
- DVAX TTM cash from financing is higher than 9.70% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM Cash From Financing | -$202.74M | -1.3% | -10000.0% | -693.0% | -285.3% | |
| Annual Cash From Financing | -$102.02M | – | -7460.5% | -282.9% | -166.1% | |
| Quarterly Cash From Financing | -$61.00K | +99.9% | -102.5% | -100.8% | -104.3% | |
| Price | $15.41 | +48.9% | +22.1% | +50.0% | +208.8% | |
| TTM Cash From Operations | $90.63M | +18.8% | +232.4% | -38.9% | +191.1% | |
| TTM Cash From Investing | $152.39M | +39.0% | +347.2% | +166.8% | +1051.1% | |
| TTM Dividends Paid | $0.00 | 0.0% | 0.0% | 0.0% | 0.0% | |
| Quarterly Total Debt | $289.22M | -0.1% | +13.6% | +12.2% | +32.4% | |
| Shares Outstanding | 117.43M | – | -6.4% | -8.0% | +6.6% |
TTM Cash From Financing Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$102.02M | N/A | -98.7% |
| 3Y | $19.53M | N/A | -1138.3% |
| 5Y | $127.26M | -259.3% | |
| All | $257.28M | -178.8% |
TTM Cash From Financing Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$202.74M | at low | |
| 3Y | -$202.74M | at low | |
| 5Y | -$202.74M | at low | |
| All | -$202.74M | at low |
TTM Cash From Financing History
FAQ
What is the current TTM cash from financing of DVAX?
As of today, DVAX TTM cash from financing is -$202.74M
What is DVAX TTM cash from financing most recent change?
DVAX TTM cash from financing was down -1.27% on September 30, 2025
What is 1-year change in DVAX TTM cash from financing?
DVAX TTM cash from financing is down -14741.58% year-over-year
How far is DVAX TTM cash from financing from its all-time high?
DVAX TTM cash from financing is currently -178.80% below its historical high of $257.28M set on March 31, 2018
How does DVAX TTM cash from financing rank versus sector peers?
DVAX TTM cash from financing is higher than 9.70% of companies in Healthcare sector
When is DVAX next earnings release?
The next earnings release for DVAX is on
Cash From Financing Formula
Data Sources & References
- DVAX Official Website www.dynavax.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1029142/000162828025049536/0001628280-25-049536-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1029142/000102914225000049/0001029142-25-000049-index.htm
- DVAX Profile on Yahoo Finance finance.yahoo.com/quote/DVAX
- DVAX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/dvax
